Preclinical animal models of asthma have further shown that inhibition of EGFR activation reduces allergen-induced eosinophil influx, MUC51 protein expression in bronchoalveolar lavage (BAL), AHR and epithelial and airway smooth muscle (ASM) remodeling5, 12, 13. Here, EGFR is linked to asthma.